Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.
Read More…
Industry, Sector and Symbol
Industry N/A
Sub-IndustryHealth Care Equipment
SectorN/A
WebN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
Employees5,527
Next Earnings Date4/16/2020 (Estimated)
OptionableOptionable
Intuitive Surgical (NASDAQ:ISRG) Frequently Asked Questions
What is Intuitive Surgical's stock symbol?
Intuitive Surgical trades on the NASDAQ under the ticker symbol "ISRG."
When did Intuitive Surgical's stock split? How did Intuitive Surgical's stock split work?
Intuitive Surgical's stock split on the morning of Friday, October 6th 2017. The 3-1 split was announced on Friday, August 11th 2017. The newly issued shares were distributed to shareholders after the closing bell on Thursday, October 5th 2017. An investor that had 100 shares of Intuitive Surgical stock prior to the split would have 300 shares after the split.
How were Intuitive Surgical's earnings last quarter?
Intuitive Surgical, Inc. (NASDAQ:ISRG) issued its quarterly earnings results on Thursday, January, 23rd. The medical equipment provider reported $3.48 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $3.38 by $0.10. The medical equipment provider earned $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. Intuitive Surgical's revenue for the quarter was up 22.1% on a year-over-year basis. During the same quarter last year, the business posted $2.96 EPS. View Intuitive Surgical's Earnings History.
When is Intuitive Surgical's next earnings date?
What guidance has Intuitive Surgical issued on next quarter's earnings?
Intuitive Surgical issued an update on its fourth quarter 2019
After-Hours earnings guidance on Thursday, January, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.278-1.278 billion, compared to the consensus revenue estimate of $1.22 billion.
What price target have analysts set for ISRG?
16 analysts have issued 1 year target prices for Intuitive Surgical's shares. Their forecasts range from $375.00 to $725.00. On average, they anticipate Intuitive Surgical's share price to reach $622.15 in the next year. This suggests a possible upside of 3.1% from the stock's current price. View Analyst Price Targets for Intuitive Surgical.
What is the consensus analysts' recommendation for Intuitive Surgical?
16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last year. There are currently 1 sell rating, 5 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Intuitive Surgical.
What are Wall Street analysts saying about Intuitive Surgical stock?
Here are some recent quotes from research analysts about Intuitive Surgical stock:
- 1. According to Zacks Investment Research, "Intuitive Surgical has outperformed the industry over the past six months. Notably, flagship da Vinci procedures recorded solid growth in the last reported quarter which drove the core Instrument & Accessories arm. In fact, management continues to expect strong procedure growth in 2019. The company looks to accelerate its business in China, which saw a solid third quarter as well. Overall international sales surged in the quarter. Expansion in gross margin is an added positive. On the flip side, contraction in operating margin is worrisome. Additionally, the da Vinci system is in the early stages of adoption in some of the markets outside the United States, which is likely to impede placements. Intense competition in the global MedTech space is concerning as well." (1/22/2020)
- 2. BTIG Research analysts commented, "like we previewed, ISRG posted a healthy beat on procedures and system units placed but reported a slight miss on sales (increased leases) and opex came in near the top end of guidance, causing EPS to miss. We understand the benefits of offering several routes to system acquisition and the leases do not bother us. Getting more systems out there and surgeons trained before any significant competition makes sense. The continued increased spending is a concern. While we gather robotics is in the early days, the increased spending started a few years ago and what was initially discussed as a one- or two-year plan has become now at least a three- or four-year plan that seems like it may last a long time. With guidance revised to a 24-28% y/y increase vs the initial 20-28%, investors may pause." (4/21/2019)
Has Intuitive Surgical been receiving favorable news coverage?
News headlines about ISRG stock have trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of media coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Intuitive Surgical earned a news impact score of 2.0 on InfoTrie's scale. They also gave media stories about the medical equipment provider a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for Intuitive Surgical.
Are investors shorting Intuitive Surgical?
Intuitive Surgical saw a increase in short interest in January. As of January 15th, there was short interest totalling 1,840,000 shares, an increase of 20.3% from the December 31st total of 1,530,000 shares. Based on an average daily trading volume, of 589,800 shares, the days-to-cover ratio is currently 3.1 days. Currently, 1.6% of the shares of the stock are sold short. View Intuitive Surgical's Current Options Chain.
Who are some of Intuitive Surgical's key competitors?
Some companies that are related to Intuitive Surgical include Abbott Laboratories (ABT), ABIOMED (ABMD), CONMED (CNMD), ProShares UltraShort DJ-UBS Commodity (CMD), Synthorx (THOR), AtriCure (ATRC), AngioDynamics (ANGO), Alphatec (ATEC), Accuray (ARAY), Fc Global Realty (FCRE), Navidea Biopharmaceuticals (NAVB), Baxter International (BAX), Becton Dickinson and (BDX), Boston Scientific (BSX) and Cardiovascular Systems (CSII).
What other stocks do shareholders of Intuitive Surgical own?
Who are Intuitive Surgical's key executives?
Intuitive Surgical's management team includes the folowing people:
- Dr. Gary S. Guthart, CEO, Pres & Director (Age 53)
- Mr. Marshall L. Mohr, Exec. VP & CFO (Age 63)
- Mr. Salvatore J. Brogna, Exec. VP & COO (Age 64)
- Mr. David J. Rosa, Exec. VP & Chief Bus. Officer (Age 51)
- Dr. Myriam J. Curet McAdams, Exec. VP & Chief Medical Officer (Age 62)
Who are Intuitive Surgical's major shareholders?
Intuitive Surgical's stock is owned by a number of of institutional and retail investors. Top institutional investors include FMR LLC (6.06%), State Street Corp (4.19%), Bank of New York Mellon Corp (2.52%), Edgewood Management LLC (2.35%), Jennison Associates LLC (2.19%) and Baillie Gifford & Co. (1.88%). Company insiders that own Intuitive Surgical stock include Alan J Levy, Amal M Johnson, Craig H Barratt, Curet Myriam, David J Rosa, Gary S Guthart, Jamie Samath, Keith R Leonard, Lonnie M Smith, Mark J Meltzer, Mark J Rubash, Marshall Mohr, Michael A Friedman, Neeraj Gupta, Reiter Kara Andersen and Salvatore Brogna. View Institutional Ownership Trends for Intuitive Surgical.
Which institutional investors are selling Intuitive Surgical stock?
ISRG stock was sold by a variety of institutional investors in the last quarter, including Marshall Wace North America L.P., Fred Alger Management LLC, Point72 Asset Management L.P., Sei Investments Co., Meitav Dash Investments Ltd., Los Angeles Capital Management & Equity Research Inc., Assenagon Asset Management S.A. and State of Michigan Retirement System. Company insiders that have sold Intuitive Surgical company stock in the last year include Alan J Levy, Curet Myriam, Gary S Guthart, Jamie Samath, Keith R Leonard, Lonnie M Smith, Mark J Rubash, Marshall Mohr, Michael A Friedman, Neeraj Gupta, Reiter Kara Andersen and Salvatore Brogna. View Insider Buying and Selling for Intuitive Surgical.
Which institutional investors are buying Intuitive Surgical stock?
ISRG stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, Johanson Financial Advisors Inc., Renaissance Technologies LLC, State Street Corp, Bank of New York Mellon Corp, Lord Abbett & CO. LLC, Baillie Gifford & Co. and Retirement Systems of Alabama. View Insider Buying and Selling for Intuitive Surgical.
How do I buy shares of Intuitive Surgical?
Shares of ISRG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Intuitive Surgical's stock price today?
One share of ISRG stock can currently be purchased for approximately $603.36.
MarketBeat Community Rating for Intuitive Surgical (NASDAQ ISRG)
MarketBeat's community ratings are surveys of what our community members think about Intuitive Surgical and other stocks. Vote "Outperform" if you believe ISRG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ISRG will underperform the S&P 500 over the long term. You may vote once every thirty days.
